Epidemiological aspects and world distribution of HTLV-1 infection

Frontiers in Microbiology

Volumn 3, Issue NOV, 2012, Pages

  Gessain, Antoine ^a,b   Cassar, Olivier ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

HTLV 1; HTLV 1 epidemiology; HTLV 1 in Africa; HTLV 1 in Asia; HTLV 1 in Europe; HTLV 1 in Oceania; HTLV 1 in the Americas; HTLV 1 world distribution

Indexed keywords

EID: 84875870265     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00388     Document Type: Review

References (361)

1. Abbaszadegan, M. R., Gholamin, M., Tabatabaee, A., Farid, R., Housh-mand, M., and Abbaszadegan, M. (2003). Prevalence of human T-lymphotropic virus type 1 among blood donors from Mash-had, Iran. J. Clin. Microbiol. 41, 2593-2595.
2. Ades, A. E., Parker, S., Walker, J., Edginton, M., Taylor, G. P., and Weber, J. N. (2000). Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study. BMJ 320, 1497-1501.
3. Ahmed, F., Murthy, S. S., Mohan, M. V., and Rajappa, S. J. (2012). HTLV 1 associated adult T cell lymphoma/leukemia a clinicopatho-logic, immunophenotypic tale of three cases from non-endemic region of south India. Indian J. Pathol Mkrobiol 55, 92-96.
4. Ajdukiewicz, A., Yanagihara, R., Gar-ruto, R. M., Gajdusek, D. C., and Alexander, S. S. (1989). HTLV-1 myeloneuropathy in the Solomon Islands. N. Engl.J. Med. 321, 615-616.
5. Alarcon, J. O., Friedman, H. B., Mon-tano, S. M., Zunt, J. R., Holmes, K. K., and Quinnan, G. V. Jr. (2006). High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru. J. Acquir. Immune Defic. Syndr. 42, 604-609.
6. Allain, J. P., Hodges, W., Einstein, M. H., Geisler, J., Neilly, C., Delaney, S., et al. (1992). Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians. J. Acquir. Immune Defic. Syndr. 5, 1230-1236.
7. Al-Mufti, S., Voevodin, A., Ahmed, S., Al-Hamdan, S., and Al-Bisher, A. A. (1997). Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 88-90.
8. Ampofo, W., Nii-Trebi, N., Ansah, J., Abe, K., Naito, H., Aidoo, S., et al. (2002). Prevalence of blood-borne infectious diseases in blood donors in Ghana. J. Clin. Microbiol. 40, 3523-3525.
9. Analo, H. I., Akanmu, A. S., Akin-sete, I., Njoku, O. S., and Okany, C. C. (1998). Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. Cent. Afr. J. Med. 44, 130-134.
10. Andersson, S., Dias, F., Mendez, P. J., Rodrigues, A., and Biberfeld, G. (1997). HTLV-I and -II infections in a nationwide survey of pregnant women in Guinea-Bissau, West Africa. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 320-322.
11. Ando, Y., Nakano, S., Saito, K., Shi-mamoto, I., Ichijo, M., Toyama, T., et al. (1987). Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle- with breast-fed babies. Jpn. J. Cancer Res. 78, 322-324.
12. Arango, C., Concha, M., Zaninovic, V., Corral, R., Biojo, R., Borrero, I., et al. (1988). Epidemiology of tropical spastic paraparesis in Columbia and associated HTLV-I infection. Ann. Neurol. 23(Suppl.), S161-S165.
13. Araujo, A. Q., Andrade-Filho, A. S., Castro-Costa, C. M., Menna-Barreto, M., and Almeida, S. M. (1998). HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19, 536-541.
14. Arif, M., and Ramia, S. (1998). Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia. Ann. Trop. Med. Parasitol. 92, 305-309.
15. Armah, H. B., Narter-Olaga, E. G., Adjei, A. A., Asomaning, K., Gyasi, R. K., and Tettey, Y. (2006). Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. J. Med. Microbiol. 55, 765-770.
16. Au, W. Y., and Lo, J. Y (2005). HTLV-1 -related lymphoma in Hong Kong Chinese. Am. J. Hematol. 78, 80-81.
17. Azarpazhooh, M. R., Hasanpour, K., Ghanbari, M., Rezaee, S. A., Mashkani, B., Hedayati-Moghaddam, M. R., et al. (2012). Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic Analysis. AIDS Res. Hum. Retroviruses 28, 1095-1101.
18. Babu, P. G., Gnanamuthu, C., Saraswathi, N. K., Nerurkar, V. R., Yanagihara, R., and John, T. J. (1993). HTLV-I-associated myelopathy in south India. AIDS Res. Hum. Retroviruses 9, 499-500.
19. Becker, W. B., Becker, M. L., Homma, T., Brede, H. D., and Kurth, R. (1985). Serum antibodies to human T-cell leukaemia virus type I in different ethnic groups and in non-human primates in South Africa. S. Afr. Med. I 67,445-449.
20. Beltran, B., Quinones, P., Morales, D., Cotrina, E., and Castillo, J. J. (2011). Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leuk. Res. 35, 334-339.
21. Berini, C. A., Gendler, S. A., Pascuccio, S., Eirin, M. E., McFarland, W., Page, K., et al. (2010). Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J. Med. Virol. 82, 873-877.
22. Bernvil, S. S., Andrews, V., and Coulter, N. (1997). International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective? Transfus. Sci. 18,45-47.
23. Bertherat, E., Makuwa, M., Renaut, A., Nabias, R., and Georges-Courbot, M. C. (1998). HIV-1, HTLV-I, and HTLV-II in a semiurban population in East Gabon. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19, 430-432.
24. Besson, C., Gonin, C., Brebion, A., Delaunay, C., Panelatti, G., and Plumelle, Y (2001). Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15, 828-831.
25. Bhagavati, S., Ehrlich, G., Kula, R. W., Kwok, S., Sninsky, J., Udani, V., et al. (1988). Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N. Engl J. Med. 318,1141-1147.
26. Bhatt, N. B., Gudo, E. S., Sema, C., Bila, D., Di Mattei, P., Augusto, O., et al. (2009). Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients. Int. J. STD AIDS 20, 863-868.
27. Bhigjee, A. I., Kelbe, C., Haribhai, H. C., Windsor, I. M., Hoffmann, M. H., Modi, G., et al. (1990). Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in natal, South Africa. A clinical and investigative study in 24 patients. Brain 113(Pt 5), 1307-1320.
28. Bhigjee, A. I., Thaler, D., Madurai, S., Gouws, E., and Bill, P. L. (1994). Seroprevalence of HTLV-I in Natal/KwaZulu. S. Afr. Med. J. 84, 368.
29. Bhigjee, A. I., Vinsen, C., Windsor, I. M., Gouws, E., Bill, P. L., and Tait, D. (1993). Prevalence and transmission of HTLV-I infection in Natal/KwaZulu. S. Afr. Med. J. 83, 665-667.
30. Biggar, R. J., Neequaye, J. E., Nee-quaye, A. R., Ankra-Badu, G. A., Levine, P. H., Manns, A., et al. (1993). The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa. AIDS Res. Hum. Retroviruses 9, 505-511.
31. Biggar, R. J., Saxinger, C., Gardiner, C., Collins, W. E., Levine, P. H., Clark, J. W., et al. (1984). Type-I HTLV antibody in urban and rural Ghana, West Africa. Int. J. Cancer 34,215-219.
32. Biglione, M. M., Astarloa, L., and Salomon, H. E. (2005). High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern. AIDS Res. Hum. Retroviruses 21,1-4.
33. Biglione, M. M., Pizarro, M., Puca, A., Salomon, H. E., and Berria, M. I. (2003). A cluster of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina. J. Acquir. Immune Defic. Syndr. 32,441-445.
34. Bitar, N., Hajj, H. E., Houmani, Z., Sabbah, A., Otrock, Z. K., Mah-fouz, R., et al. (2009). Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon. Transfusion 49, 1859-1864.
35. Bittencourt, A. L., Barbosa, H. S., Vieira, M. D., and Farre, L. (2009). Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histolog-ical and immunohistochemical features of 52 cases. Acta Oncol. 48, 598-604.
36. Bittencourt, A. L., Dourado, I., Filho, P. B., Santos, M., Valadao, E., Alcantara, L. C., et al. (2001). Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J. Acquir. Immune Defic. Syndr. 26,490-494.
37. Blakeslee, J. R. Jr., McClure, H. M., Anderson, D. C., Bauer, R. M., Huff, L. Y., and Olsen, R. G. (1987). Chronic fatal disease in gorillas seropositive for simian T-lymphotropic virus I antibodies. Cancer Lett. 37, 1-6.
38. Blank, A., Yamaguchi, K., Blank, M., Zaninovic, V., Sonoda, S., and Takatsuki, K. (1993). Six Colombian patients with adult T-cell leukemia/lymphoma. Leuk. Lymphoma 9,407-412.
39. Blattner, W A., Nomura, A., Clark, J. W., Ho, G. Y., Nakao, Y., Gallo, R., et al. (1986). Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc. Natl Acad. Sci. U.S.A. 83, 4895-4898.
40. Blattner, W. A., Saxinger, C., Riedel, D., Hull, B., Taylor, G., Cleghorn, F., et al. (1990). A study of HTLV-I and its associated risk factors in Trinidad and Tobago. J. Acquir. Immune Defic. Syndr. 3, 1102-1108.
41. Blayney, D. W., Jaffe, E. S., Blattner, W. A., Cossman, J., Robert-Guroff, M., Longo, D. L., et al. (1983). The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. Blood 62,401-405.
42. Brady-West, D. C., and Buchner, L. M. (2000). Retrospective audit of blood donation at a hospital-based blood centre. Implications for blood product supply and safety. West Indian Med.J. 49, 226-228.
43. Brant, L. J., Cawley, C., Davison, K. L., and Taylor, G. P. (2011). Recruiting individuals into the HTLV cohort study in the United Kingdom: clinical findings and challenges in the first six years, 2003 to 2009. Euro Surveill. 16, pii=20017.
44. Cabrera, M. E., Gray, A. M., Cartier, L., Araya, F., Hirsh, T., Ford, A. M., et al. (1991). Simultaneous adult T-cell leukemia/lymphoma and sub-acute polyneuropathy in a patient from Chile. Leukemia 5, 350-353.
45. Calderon, E. J., Rey, C., Medrano, F. J., Sanchez-Roman, J., Soriano, V., Torres, Y., et al. (1995). Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain. Eur. J. Clin. Microbiol. Infect. Dis. 14, 686-690.
46. Cantor, K. P., Weiss, S. H., Goedert, J. J., and Battjes, R. J. (1991). HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J. Acquir. Immune Defic. Syndr. 4, 460-467.
47. Carles, G., Tortevoye, P., Tuppin, P., Ureta-Vidal, A., Peneau, C., El Guindi, W., et al. (2004). HTLV1 infection and pregnancy. J. Gynecol. Obstet. Biol. Reprod. (Paris) 33, 14-20.
48. Carneiro-Proietti, A. B., Sabino, E. C., Leao, S., Salles, N. A., Loureiro, P., Sarr, M., et al. (2012). Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. AIDS Res. Hum. Retroviruses 28, 1265-1272.
49. Cartier, L., Araya, F., Castillo, J. L., Ruiz, F., Gormaz, A., and Tajima, K. (1992). Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I). Intern. Med. 31, 1257-1261.
50. Cartier, L., Mora, C., Araya, F., Castillo, J., Verdugo, R., and Miller, M. (1989). HTLV-I positive spastic paraparesis in a temperate zone. Lancet 1, 556.
51. Cassar, O., Capuano, C., Bassot,S., Char-avay, F., Duprez, R., Afonso, P. V., et al. (2007). Human T lymphotropic virus type 1 subtype C melane-sian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor. J. Infect. Dis. 196,510-521.
52. Catalan-Soares, B., Carneiro-Proietti, A. B., and Proietti, E A. (2005). Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): sero-logical screening prevalence rates in blood donors from large urban areas in Brazil. Cad. Saude Publica 21, 926-931.
53. Caterino-de-Araujo, A., Magri, M. C., Costa, E. A., and Manuel, R. C. (2010). Prevalence of human T-cell lymphotropic virus (HTLV-1/2) in individuals from public health centers in Mozambique. AIDS Res. Hum. Retroviruses 26, 559-561.
54. Catovsky, D., Greaves, M. F., Rose, M., Galton, D. A., Goolden, A. W., McCluskey, D. R., et al. (1982). Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet 1,639-643.
55. Ceesay, M. M., Matutes, E., Taylor, G. P., Fields, P., Cavenagh, J., Simpson, S., et al. (2012). Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL). Leuk. Res. 36, 857-861.
56. Cesaire, R., Bera, O., Maier, H., Lezin, A., Martial, J., Ouka, M., et al. (1999). Seroin determinate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 39, 1145-1149.
57. Chandy, M., Babu, P. G., Saraswathy, N. K., Ishida, T., and John, T. J. (1991). HTLV-1 infection in patients with leukaemia in southern India. Lancet 338,380-381.
58. Chavance, M., Frery, N., Valette, I., Mon-plaisir, N., and Schaffar, L. (1989). Cohort effect of HTLV-I seroprevalence in southern Japan. Lancet 2, 1337.
59. Chen, Y. M., Ting, S. T., Lee, C. M., Liu, W. T., Pan, W H., Cheng, A. T., et al. (1999). Community-based molecular epidemiology of HTLV type I in Taiwan and Kinmen: implication of the origin of the cosmopolitan subtype in northeast Asia. AIDS Res. Hum. Retroviruses 15, 229-237.
60. Chiavetta, J., Nusbacher, J., Tarn, E, Wall, A., Steaffens, J., and Lee, H. (1992). Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto. CMAJ 147, 1493-1498.
61. Chironna, M., Calabro, M. L., Quarto, M., Germinario, C., Fiore, J. R., Favero, A., et al. (1996). HTLV-I and HTLV-II infections in subjects at risk for HIV-I infection from southeastern Italy (Apulia region). Int. J. Cancer 65, 746-750.
62. Chungue, E., Boutin, J. P., Le Marc-hand, L., Philippon, G., Le Guellec, A., Chanteau, S., et al. (1993). Sero-epidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji. Eur. J. Epidemiol. 9, 347-350.
63. Clark, J., Saxinger, C., Gibbs, W N., Lofters, W., Lagranade, L., Deceu-laer, K., et al. (1985). Seroepi-demiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. Int. J. Cancer 36, 37-41.
64. Cnudde, F., Gessain, A., Dandelot, J. B., Carlier, P., Julvez, J., Andri-ambao, P. S., et al. (1991). HTLV-I in neurological patients from some Indian Ocean islands. J. Acquir. Immune Defic. Syndr. 4, 734-735.
65. Collenberg, E., Ouedraogo, T., Ganame, J., Fickenscher, H., Kynast-Wolf, G., Becher, H., et al. (2006). Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J. Med. Virol. 78, 683-692.
66. Courouce, A. M., Pillonel, J., Lemaire, J. M., Maniez, M., and Brunet, J. B. (1993). Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 7, 841-847.
67. Courtois, F., Barin, F., Larsen, M., Brossard, Y., Masselin, A., and Engel-man, P. (1990). HTLV-I/II infection in pregnant women in Paris. Lancet 335,1103.
68. Cunha, L., Plouzeau, C., Ingrand, P., Gudo, J. P., Ingrand, I., Mondlane, J., et al. (2007). Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J. Med. Virol. 79,1832-1840.
69. da Silva, Z. J., Nielsen, J., Andersen, A., Oliveira, I., Dias, F., Rodrigues, A., et al. (2009). Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections. AIDS 23, 637-639.
70. Daisley, H., Charles, W., Landeau, P., Jackman, L., Batson, M., and Gomez-Adams, K. (1991). Screening for HTLV-1 in healthy blood donors in Trinidad and Tobago, West Indies. Trop. Med. Parasitol. 42, 404-406.
71. Dalekos, G. N., Zervou, E., Karabini, E, Elisaf, M., Bourantas, K., and Siamopoulos, K. C. (1995). Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion 35, 503-506.
72. Davidson, F., Lycett, C., Jarvis, L. M., Kerr, D., Lumley, S., Petrik, J., et al. (2006). Detection of HTLV-I and -II in Scottish blood donor samples and archive donations. Vox Sang. 91, 231-236.
73. de Oliveira, M. S., Matutes, E., Famadas, L. C., Schulz, T. F., Calabro, M. L., Nucci, M., et al. (1990). Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 336, 987-990.
74. de Rivera, I. L., Amador, L., Mourra, S., Li, Z., and Rasheed, S. (1995). Geographical clustering of human T-cell lymphotropic virus type 1 infection in Honduras. J. Clin. Microbiol. 33, 2999-3003.
75. de The, G., and Bomford, R. (1993). An HTLV-I vaccine: why, how, for whom? AIDS Res. Hum. Retroviruses 9,381-386.
76. de The, G., and Gessain, A. (1986). Seroepidemiologic data on viral infections (HTLV-I and LAV/HTLV-III) in the Caribbean region and intertropical Africa. Ann. Pathol. 6, 261-264.
77. Dekaban, G. A., Oger, J. J., Foti, D., King, E. E., Waters, D. J., Picard, E J., et al. (1994). HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis. Clin. Diagn. Virol. 2, 67-78.
78. Del Mistro, A., Chotard, J., Hall, A. J., Fortuin, M., Whittle, H., De Rossi, A., et al. (1994). HTLV-I/II seroprevalence in the Gambia: a study of mother-child pairs. AIDS Res. Hum. Retroviruses 10, 617-620.
79. Delaporte, E., Buve, A., Nzila, N., Goe-man, J., Dazza, M. C., Henzel, D., et al. (1995). HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaire: how important is high-risk sexual behavior? J. Acquir. Immune Defic. Syndr. Hum. Retrovi-rol. 8,511-515.
80. Delaporte, E., Dupont, A., Peeters, M., Josse, R., Merlin, M., Schrijvers, D., et al. (1988). Epidemiology of HTLV-I in Gabon (Western Equatorial Africa). Int. J. Cancer 42, 687-689.
81. Delaporte, E., Monplaisir, N., Louwagie, J., Peeters, M., Martin-Prevel, Y., Louis, J. P., et al. (1991). Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int. J. Cancer 49, 373-376.
82. Delaporte, E., Peeters, M., Durand, J. P., Dupont, A., Schrijvers, D., Bed-jabaga, L., et al. (1989a). Sero-epidemiological survey of HTLV-I infection among randomized populations of western central African countries. J. Acquir. Immune Defic. Syndr. 2,410-413.
83. Delaporte, E., Peeters, M., Simoni, M., and Piot, P. (1989b). HTLV-I infection in western equatorial Africa. Lancet 2, 1226.
84. Denic, S., Abramson, J., Anandakrish-nan, R., Krishnamurthy, M., and Dosik, H. (1988). The first report of familial adult T-cell leukemia lym-phoma in the United States. Am. J. Hematol. 27, 281-283.
85. Denic, S., Nolan, P., Doherty, J., Garson, J., Tuke, P., and Tedder, R. (1990). HTLV-I infection in Iraq. Lancet 336, 1135-1136.
86. Denis, F., Verdier, M., Chout, R., Ramiandrisoa, H., Sangare, A., Prince-David, M., et al. (1988). Prevalence of HTLV-1 virus in pregnant women in Black Africa, Martinique, and foreigners living in France. Bull. Acad. Natl. Med. 172, 717-722.
87. de-The, G., Gessain, A., Gazzolo, L., Robert-Guroff, M., Najberg, G., Calender, A., et al. (1985). Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res. 45, 4633s-4636s.
88. Diop, S., Calattini, S., Abah-Dakou, J., Thiam, D., Diakhate, L., and Gessain, A. (2006). Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal. J. Clin. Microbiol. 44, 1550-1554.
89. Dixon, P. S., Bodner, A. J., Okihiro, M., Milbourne, A., Diwan, A., and Nakamura, J. M. (1990). Human T-lymphotropic virus type I (HTLV-I) and tropical spastic parapare-sis or HTLV-I-associated myelopa-thy in Hawaii. West. J. Med. 152, 261-267.
90. Dosik, H., Denic, S., Patel, N., Krishnamurthy, M., Levine, P. H., and Clark, J. W. (1988). Adult T-cell leukemia/lymphoma in Brooklyn. JAMA 259,2255-2257.
91. Dougan, S., Smith, A., Tosswill, J. C., Davison, K., Zuckerman, M., and Taylor, G. P. (2005). New diagnoses of HTLV infection in England and Wales: 2002-2004. Euro Surveill. 10, 232-235.
92. Dourado, I., Alcantara, L. C., Barreto, M. L., da Gloria Teixeira, M., and Galvao-Castro, B. (2003). HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J. Acquir. Immune Defic. Syndr. 34,527-531.
93. Dowe, G., King, S. D., Smikle, M. E, Wynter, H. H., Chout, R., and Klaskala, W. (1998). Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women. West Indian Med. J. 47, 23-25.
94. Dumas, M., Houinato, D., Verdier, M., Zohoun, T., Josse, R., Bonis, J., et al. (1991). Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa). AIDS Res. Hum. Retroviruses 7, 447-451.
95. Duval, A., Rivet, J., Moulonguet, I., Cassar, O., Agbalika, F., Wallach, D., et al. (2010). Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: prurigo nodularis lasting twelve years followed by an acute micropapular eruption. Acta Derm. Venereol. 90,287-290.
96. Eguchi, K., Fujii, H., Oshima, K., Otani, M., Matsuo, T., and Yamamoto, T. (2009). Human T-lymphotropic virus type 1 (HTLV-1) genetic typing in Kakeroma Island, an island at the crossroads of the ryukyuans and Wajin in Japan, providing further insights into the origin of the virus in Japan. J. Med. Virol. 81,1450-1456.
97. Einsiedel, L., Fernandes, L., Spelman, T., Steinfort, D., and Gotuzzo, E. (2012). Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin. Infect. Dis. 54, 43-50.
98. Einsiedel, L., Verdonck, K., and Gotuzzo, E. (2010). "Human T-lymphotropic virus 1: clinical aspects of a neglected infection among indigenous populations," in Emerging Infections, Vol. 9, eds M. W. Scheld, L. M. Grayson, and M. J. Hughes (Washington, DC: ASM Press), 109-127.
99. el-Farrash, M. A., Badr, M. F., Hawas, S. A., el-Nashar, N. M., Imai, J., Komoda, H., et al. (1988). Sporadic carriers of human T-lymphotropic virus type I in northern Egypt. Microbiol. Immunol. 32, 981-984.
100. El-ghazzawi, E., Hunsmann, G., and Schneider, J. (1987). Low prevalence of antibodies to HIV-1 and HTLV-I in Alexandria, Egypt. AIDS Forsch. 2, 639.
101. El-Hazmi, M. M. (2004). Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med. J. 25, 26-33.
102. Engelbrecht, S., Koulinska, I., Smith, T. L., Robson, B. A., Barreto, J., and van Rensburg, E. J. (1999). Subtyping of human T cell lymphotropic virus type I from tropical spastic paraparesis/HTLV-associated myelopathy patients in Mozambique. AIDS Res. Hum. Retroviruses 15, 71-72.
103. Estrada, R. A., Luis, S., Mustelier, R., Ruiz, W., Rodriguez, B., Miranda, A., et al. (1995). Absence of human retroviral antibodies in epidemic neuropathy in Cuba: report of the first two cases of HTLV-I-associated tropical spastic paraparesis observed in Cuba. J. Neurol. Sci. 128, 112-113.
104. Etenna, S. L., Caron, M., Besson, G., Makuwa, M., Gessain, A., Mahe, A., et al. (2008). New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa. J. Clin. Microbiol. 46, 3607-3614.
105. Ferrante, P., Mancuso, R., Zuffolato, R., Puricelli, S., Mannella, E., Romano, L., et al. (1997). Molecular analysis of HTLV-I and HTLV-II isolates from Italian blood donors, intravenous drug users and prisoners. New Microbiol. 20, 93-104.
106. Figueiro-Filho, E. A., Senefonte, F. R., Lopes, A. H., de Morais, O. O., Souza Junior, V G., Maia, T. L., et al. (2007). Frequency of HIV-1, rubella, syphilis, toxoplasmo-sis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Cha-gas disease and HTLV I/II infection in pregnant women of State of Mato Grosso do Sul. Rev. Soc. Bras. Med. Trop.40, 181-187.
107. Filippone, C., Bassot, S., Betsem, E., Tortevoye, P., Guillotte, M., Mercereau-Puijalon, O., et al. (2012). A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiologi-cal determinants and PCR results in central African inhabitants. J. Clin. Microbiol. 50, 1663-1672.
108. Fleming, A. F., Maharajan, R., Abraham, M.,Kulkarni,A. G.,Bhusnurmath,S. R., Okpara, R. A., et al. (1986). Antibodies to HTLV-I in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases. Int. J. Cancer 38, 809-813.
109. Fouchard, N., Mahe, A., Huerre, M., Fraitag, S., Valensi, F., Macintyre, E., et al. (1998). Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases. Leukemia 12, 578-585.
110. Freeman, R. C., Rodriguez, G. M., and French, J. F. (1995). Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New Jersey. J. Addict. Dis. 14, 51-66.
111. Fujiyoshi, T., Li, H. C., Lou, H., Yashiki, S., Karino, S., Zaninovic, V., et al. (1999). Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res. Hum. Retroviruses 15, 1235-1239.
112. Furusyo, N., Hayashi, J., Kakuda, K., Sawayama, Y., Ariyama, I., Eddie, R., et al. (1999). Markedly high seroprevalence of hepatitis B virus infection in comparison to hepatitis C virus and human T lymphotropic virus type-1 infections in selected Solomon Islands populations. Am. J. Trop. Med. Hyg. 61, 85-91.
113. Gabarre, J., Gessain, A., Raphael, M., Merle-Beral, H., Dubourg, O., Four-cade, C., et al. (1993). Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lym-phomatous involvement in an Iranian woman: clinical, immunopatho-logical and viromolecular studies. Leukemia 7, 1904-1909.
114. Galvao-Castro, B., Loures, L., Rodriques, L. G., Sereno, A., Ferreira Junior, O. C., Franco, L. G., et al. (1997). Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37, 242-243.
115. Gascoyne, R. D., Kim, S. M., Oger, J. J., Melosky, B. L., and Dekaban, G. A. (1996). HTLV-I associated adult T cell leukemia/lymphoma: report of two cases from an Amerindian population in coastal northwest British Columbia. Leukemia 10, 552-557.
116. Gasmi, M., Farouqi, B., d'Incan, M., and Desgranges, C. (1994). Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res. Hum. Retroviruses 10, 1313-1315.
117. Gastaldello, R., Hall, W. W., and Gallego, S. (2004). Seroepidemiol-ogy of HTLV-I/II in Argentina: an overview. J. Acquir. Immune Defic. Syndr. 35,301-308.
118. Gerard, Y., Lepere, J. F., Pradinaud, R., Joly, F., Lepelletier, L., Jou-bert, M., et al. (1995). Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana. Int. J. Cancer 60, 773-776.
119. Gessain, A. (2011). Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases. Bull. Soc. Pathol. Exot. 104,167-180.
120. Gessain, A., Caumes, E., Feyeux, C., d'Agay, M. F., Capesius, C., Gen-tilini, M., et al. (1992a). The cutaneous form of adult T-cell leukemia/lymphoma in a woman from the Ivory Coast. Clinical, immunovirologic studies and a review of the African adult T-cell leukemia/lymphoma cases. Cancer 69,1362-1367.
121. Gessain, A., Gallo, R. C., and Fran-chini, G. (1992b). Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J. Virol. 66, 2288-2295.
122. Gessain, A., and de The, G. (1996). What is the situation of human T cell lymphotropic virus type II (HTLV-II) in Africa? Origin and dissemination of genomic subtypes. J. Acquir. Immune Defic. Syndr. Hum. Retrovi-rol. 13(Suppl. 1),S228-S235.
123. Gessain, A., Fretz, C., Koulibaly, M., Boudret, M. L., Bah, A., Raphael, M., et al. (1993a). Evidence of HTLV-II infection in Guinea, West Africa. J. Acquir. Immune Defic. Syndr. 6, 324-325.
124. Gessain, A., Herve, V., Jeannel, D., Garin, B., Mathiot, C., and de-The, G. (1993b). HTLV-1 but not HTLV-2 found in pygmies from Central African Republic. J. Acquir. Immune Defic. Syndr. 6, 1373-1374.
125. Gessain, A., Gout, O., Saal, F., Daniel, M. T., Rio, B., Flandrin, G., et al. (1990a). Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France. Cancer Res. 50, 5692S- 5696S.
126. Gessain, A., Moulonguet, I., Flageul, B., Perrin, P., Capesius, C., D'Agay, M. E, et al. (1990b). Cutaneous type of adult T cell leukemia/lymphoma in a French West Indian woman. Clonal rearrangement of T-cell receptor beta and gamma genes and monoclonal integration of HTLV-I proviral DNA in the skin infiltrate. J. Am. Acad. Dermatol. 23, 994-1000.
127. Gessain, A., Saal, F., Gout, O., Daniel, M. T., Flandrin, G., de The, G., et al. (1990c). High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononu-clear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 75,428-433.
128. Gessain, A., Yanagihara, R., Franchini, G., Garruto, R. M., Jenkins, C. L., Ajdukiewicz, A. B., et al. (1991). Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc. Natl. Acad. Sci. U.S.A. 88, 7694-7698.
129. Gharibi, L., Marouan, S., Zouhair, K., Benchekroun, M., and Benchikhi, H. (2011). Fatal erythroderma in a young Moroccan. Med. Trop. (Mars) 71, 189-191.
130. Gibbs, W N., Lofters, W S., Campbell, M., Hanchard, B., LaGrenade, L., Clark, J., et al. (1984). Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoprolifer-ative disease. Int. Symp. Princess Takamatsu Cancer Res. Fund 15, 77-90.
131. Gioseffi, O. N., Nucifora, E., Fantl, D., Dufour, C., Milone, J., and Di Paolo, H. (1995). Adult HTLV-I positive leukemia-lymphoma in Argentina. Sangre (Barc) 40, 421-424.
132. Gongora-Biachi, R. A., Gonzalez-Martinez, P., Castro-Sansores, C., and Bastarrachea-Ortiz, J. (1997). Infection with HTLV virus type I-II in patients with cervico-uterine cancer in the Yucatan peninsula, Mexico. Ginecol Obstet. Mex. 65, 141-144.
133. Gongora-Biachi, R. A., Gonzalez-Martinez, P., Castro-Sansores, C., Vivas-Rosel, M. L., Gasque-Lopez, F., and Garrido-Hadad, E. (1996). Lymphotropic viruses type I and II in pregnant women in Yucatan. Rev. Invest. Clin. 48, 383-384.
134. Goto, K., Sato, K., Kurita, M., Masuhara, N., Iijima, Y., Saeki, K., et al. (1997). Serologic survey for HTLV-I in Kanagawa Prefecture. Tokai J. Exp. Clin. Med. 22, 7-8.
135. Gotuzzo, E., Cabrera, J., Deza, L., Verdonck, K., Vandamme, A. M., Cairampoma, R., et al. (2004). Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin. Infect. Dis. 39, 939-944.
136. Goubau, P., Carton, H., Kazadi, K., Muya, K. W., and Desmyter, J. (1990).HTLVseroepidemiologyina central African population with high incidence of tropical spastic paraparesis. Trans. R. Soc. Trop. Med. Hyg. 84, 577-579.
137. Goubau, P., Desmyter, J., Swanson, P., Reynders, M., Shih, J., Surmont, I., et al. (1993). Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides. J. Med. Virol. 39, 28-32.
138. Gout, O., Gessain, A., Bolgert, F., Saal, F., Tournier-Lasserve, E., Lasneret, J., et al. (1989). Chronic myelopathies associated with human T-lymphotropic virus type I. A clinical, serologic, and immunovirologic study of ten patients in France. Arch. Neurol. 46, 255-260.
139. Gracia, F., Reeves, W C, Levine, P. H., Cuevas, M., Castillo, L., Chavarria, R., et al. (1990). Human T-cell lymphotropic virus type I and neurologic disease in Panama, 1985 and 1986. Arch. Neurol. 47, 634-639.
140. Gradilone, A., Zani, M., Barillari, G., Modesti, M., Agliano, A. M., Maio-rano, G., et al. (1986). HTLV-I and HIV infection in drug addicts in Italy. Lancet 2, 753-754.
141. Grant, W., Bia, E J., Chacko, T. M., Jean-Baptiste, M., and Griffith, B. P. (1992). Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti. Diagn. Micro-biol. Infect. Dis. 15,121-124.
142. Group, R. S. (1989). Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country. Rwandan HIV Seroprevalence Study Group. Lancet 1, 941-943.
143. Gudo, E. S., Abreu, C. M., Mussa, T., Augusto Ado, R., Otsuki, K., Chambo, E., et al. (2009). Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Transfusion49, 1146-1150.
144. Guimaraes de Souza, V., Lobato Martins, M., de Freitas Carneiro-Proietti, A. B., Januario, J. N., Ladeira, R. V., Silva, C. M., et al. (2012). High prevalence of HTLV-1 and 2 viruses in pregnant women in Sao Luis, state of Maranhao, Brazil. Rev. Soc. Bras. Med. Trop. 45, 159-162.
145. Guo, H. G., Wong-Stall, F., and Gallo, R. C. (1984). Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon. Science 223, 1195-1197.
146. Hale, A., Leung, T., Sivasubramaniam, S., Kenny, J., and Sutherland, S. (1997). Prevalence of antibodies to HTLV in antenatal clinic attenders in south east London. J. Med. Virol. 52, 326-329.
147. Haque, A., Hossain, M., Khan, J. K., Kuo, Y H., Lambein, F., and De Reuck, J. (1994). New findings and symptomatic treatment for neurolathyrism, a motor neuron disease occurring in north west Bangladesh. Paraplegia 32, 193-195.
148. Harrington, W J. Jr., Ucar, A., Gill, P., Snodgrass, S., Sheremata, W., Cabral, L.,etal. (1995). Clinical spectrum of HTLV-I in south Florida. J. Acquir. Immune Defic. Syndr. Hum. Retrovi-rol. 8, 466-473.
149. Hayami, M., Komuro, A., Nozawa, K., Shotake, T., Ishikawa, K., Yamamoto, K., et al. (1984). Prevalence of antibody to adult T-cell leukemia virus-associated antigens (ATLA) in Japanese monkeys and other non-human primates. Int. J. Cancer 33, 179-183.
150. Hernandez Ramirez, P., Rivero Jimenez, R., Ballester Santovenia, M., Navea Leyva, L., Matutes, E., Catovsky, D., etal. (1991). Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients. Vox Sang. 61,277-278.
151. Hino, S. (2011). Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL prevention program Nagasaki. Proc. Jpn. Acad. Ser. BPhys. Biol. Sci. 87, 152-166.
152. Hino, S., Katamine, S., Kawase, K., Miyamoto, T., Doi, H., Tsuji, Y., et al. (1994). Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan. Leukemia 8 (Suppl. 1),S68-S70.
153. Hino, S., Sugiyama, H., Doi, H., Ishi-maru, T., Yamabe, T., Tsuji, Y., et al. (1987). Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet 2, 158-159.
154. Hino, S., Yamaguchi, K., Katamine, S., Sugiyama, H., Amagasaki, T., Kinoshita, K., et al. (1985). Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn. J. Cancer Res. 76, 474-480.
155. Hinuma, Y., Komoda, H., Chosa, T., Kondo, T., Kohakura, M., Take-naka, T., et al. (1982). Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int. J. Cancer 29,631-635.
156. Hlela, C., Shepperd, S., Khumalo, N. P., and Taylor, G. P. (2009). The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev. 11, 205-214.
157. Homma, T., Kanki, P. J., King, N. W. Jr., Hunt, R. D., O'Connell, M. J., Letvin, N. L., et al. (1984). Lymphoma in macaques: association with virus of human T lymphotrophic family. Science 225,716-718.
158. Houinato, D., Verdier, M., Josse, R., Zohoun, T., Letenneur, L., Salamon, R., et al. (1996). Seroepidemiologi-cal study of retroviruses (HTLV-I/II, HIV-1, HIV-2) in the Department of Atacora, northern Benin. Trop. Med. Int. Health 1,205-209.
159. Houston, S., Thornton, C., Emmanuel, J., and Latif, A. (1994). Human Tcell lymphotropic virus type 1 in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 88,170-172.
160. Hunsmann, G., Bayer, H., Schneider, J., Schmitz, H., Kern, P., Dietrich, M., et al. (1984). Antibodies to ATLV/HTLV-1 in Africa. Med. Microbiol. Immunol. 173, 167-170.
161. Hunsmann, G., Schneider, J., Schmitt, J., andYamamoto,N. (1983).Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa. Int. J. Cancer 32, 329-332.
162. Inaba, S., Sato, H., Okochi, K., Fukada, K., Takakura, F., Tokunaga, K., et al. (1989). Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion 29, 7-11.
163. Ishida, T., and Hinuma, Y. (1986). The origin of Japanese HTLV-I. Nature 322, 504.
164. Ishida, T., Yamamoto, K., and Omoto, K. (1988). A seroepidemiological survey of HTLV-1 in the Philippines. Int. J. Epidemiol. 17, 625-628.
165. Jain, P., Gupta, S., Prabhash, K., Patkar, N., and Parikh, P. M. (2008). Adult T cell leukemia: a typical case from India. Indian J. Cancer 45, 72-73.
166. Janssen, R. S., Kaplan, J. E., Khabbaz, R. F., Hammond, R., Lechtenberg, R., Lairmore, M., et al. (1991). HTLV-I-associated myelopathy/tropical spastic paraparesis in the United States. Neurology 41, 1355-1357.
167. Jeannel, D., Garin, B., Kazadi, K., Singa, L., and de The, G. (1993). The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire. J. Acquir. Immune Defic. Syndr. 6, 840-844.
168. Jeannel, D., Kourouma, K., Fretz, C., Zheng, Y. M., Ureta, V A., Drame, L., et al. (1995). Regional differences in human retroviral infections HIV-1, HIV-2, and HTLV-I/II in rural Guinea (west Africa). J. Acquir. Immune Defic. Syndr. Hum. Retrovi-rol. 8,315-318.
169. Jeon, H. J., Lee, M. J., Jeong, Y. K., Lee, D. M.,Oh,Y.K.,and Kim,C.W. (2000). Adult T cell leukemia/lymphoma with lymphopenia in a Korean. J. Korean Med. Sci. 15, 233-239.
170. Jogessar, V B., de Bruyn, C. C., Bhig-jee, A. I., Naicker, V L, Bill, P. L., and Tait, D. (1992). Adult T-cell leukaemia/lymphoma associated with HTLV-I in Natal. S. Afr. Med.J. 81,528-529.
171. Joubert, J., van As, A. D., Lecatsas, G., and Bos, P. (1991). Human T-lymphotropic virus type I-associated myelopathy. A case report. S. Afr. Med. J. 80, 592-593.
172. Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., and Okochi, K. (1986). Intrafamilial transmission of adult T cell leukemia virus.J. Infect. Dis. 154,851-857.
173. Kaplan, J. E., Khabbaz, R. F., Murphy, E. L., Hermansen, S., Roberts, C., Lal, R., et al. (1996). Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12, 193-201.
174. Kawashti, M. I., Hindawi, S. I., Daman-houri, G. A., Rowehy, N. G., Bawazeer, M. M., and Alshawa, M. (2005). Serologial screening of human T cell lymphotropic virus I and II (HTLV I/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat? Egypt J. Immunol. 12, 137-142.
175. Kayembe, K., Goubau, P., Desmyter, J., Vlietinck, R., and Carton, H. (1990). A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J. Neurol. Neurosurg. Psychiatr. 53,4-10.
176. Kazanji, M., and Gessain, A. (2003). Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad. Saude Publica 19, 1227-1240.
177. Kchour, G., Tarhini, M., Kooshyar, M. M., El Hajj, H., Wattel, E., Mah-moudi, M., et al. (2009). Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood 113,6528-6532.
178. Khabbaz, R. F., Hartley, T. M., Oberle, M. W., and Rosero-Bixby, L. (1990). Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Costa Rica. AIDS Res. Hum. Retroviruses 6, 959-960.
179. Kim, J. M., Song, Y. G., Oho, Y. C., Park, H. C., Kwon, K. H., Kim, E., et al. (1999). Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors. Yonsei Med. J. 40, 173-177.
180. Kimata, J. T., Kaneshiro, S. A., Kwock, D. W., Nakamura, S., Kaneshiro, M. M., and Nakamura, J. M. (1989). A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices. West. J. Med. 150,300-302.
181. Kinoshita, K., Hino, S., Amagaski, T., Ikeda, S., Yamada, Y., Suzuyama, J., etal. (1984). Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gann 75, 103-105.
182. Kirkland, M. A., Frasca, J., and Bastian, I. (1991). Adult T-cell leukaemia lymphoma in an aborigine. Aust. N Z. J. Med. 21, 739-741.
183. Kohakura, M., Nakada, K., Yonahara, M., Komoda, H., Imai, J., and Hinuma, Y. (1986). Seroepidemi-ology of the human retrovirus (HTLV/ATLV) in Okinawa where adult T-cell leukemia is highly endemic. Jpn. J. Cancer Res. 77, 21-23.
184. Koralnik, I. J., Boeri, E., Saxinger, W. C., Monico, A. L., Fullen, J., Gessain, A., et al. (1994). Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for inter-species transmission. J. Virol. 68, 2693-2707.
185. Kumar, H., and Gupta, P. K. (2006). Is seroprevalence of HTLV-I/II among blood donors in India relevant? Indian J. Pathol. Microbiol. 49, 532-534.
186. Kwon,S.Y.,Lim,A.H.,Park,J.Y.,Han,S. H., and Cho, N. S. (2008). Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors. J. Med. Virol. 80, 1864-1867.
187. La Grenade, L., Hanchard, B., Fletcher, V., Cranston, B., and Blattner, W. (1990). Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336, 1345-1347.
188. Laperche, S., Worms, B., and Pillonel, J. (2009). Blood safety strategies for human T-cell lymphotropic virus in Europe. Vox Sang. 96, 104-110.
189. Larsen, O., Andersson, S., da Silva, Z., Hedegaard, K., Sandstrom, A., Nau-cler, A., et al. (2000). Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J. Acquir. Immune Defic. Syndr. 25, 157-163.
190. Lavanchy, D., Bovet, P., Hollanda, J., Shamlaye, C. F., Burczak, J. D., and Lee, H. (1991). High seroprevalence of HTLV-I in the Seychelles. Lancet 337, 248-249.
191. Le Hesran, J. Y., Delaporte, E., Gaude-bout, C., Trebuck, A., Schrijvers, D., Josse, R., et al. (1994). Demographic factors associated with HTLV-1 infection in a Gabonese community. Int. J. Epidemiol. 23, 812-817.
192. Lechat, M. F., Shrager, D. I., Declercq, E., Bertrand, F., Blattner, W. A., and Blumberg, B. S. (1997). Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 387-390.
193. Lee, C. W., Chang, M. C., Chang, Y. F., Hsieh, R. K., Lin, J., and Chen, K. S. (2010). Adult T-cell leukemia/lymphoma in Taiwan: an analysis of 17 patients and review of the literature. Asia Pac. J. Clin. Oncol. 6, 161-164.
194. Lee, H. H., Weiss, S. H., Brown, L. S., Mildvan, D., Shorty, V., Saravolatz, L., et al. (1990). Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J. Infect. Dis. 162, 347-352.
195. Lee, S. Y., Yamaguchi, K., Takatsuki, K., Kim, B. K., Park, S., and Lee, M. (1986). Seroepidemiology of human T-cell leukemia virus type-I in the Republic of Korea. Jpn. J. Cancer Res. 77, 250-254.
196. Leon, G., Quiros, A. M., Lopez, J. L., Hung, M., Diaz, A. M., Goncalves, J., et al. (2003). Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors. Rev. Panam. Salud Publica 13, 117-123.
197. Levine, P. H., Reeves, W. C., Cuevas, M., Arosemena, J. R., Jaffe, E. S., Saxinger,W. C.,etal. (1989). Human T-cell leukemia virus-I and hemato-logic malignancies in Panama. Cancer 63, 2186-2191.
198. Li, H. C., Biggar, R. J., Miley, W. J., Maloney, E. M., Cranston, B., Han-chard, B., et al. (2004). Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J. Infect. Dis. 190, 1275-1278.
199. Louis, E J., Sapin, C., Huerre, M., Des-forges, S., Labrouasse, R., Friquet, I., et al. (1990). Prévalence à Wallis des trépanomatoses et des infections a virus HTLV-1 et HB. Médecine d'Océanie 2, 28-32.
200. Louisiriotchanakul, S., Thongput, A., Khamboonruang, C., Taylor, G. P., Kunstadter, P., and Wasi, C. (2000). No evidence of HTLV-I or HTLV-II infection among the Hmong people of northern Thailand or injecting drug users in Bangkok. J. Acquir. Immune Defic. Syndr. 23, 441-442.
201. Lu, S. C., Kao, C. L., Chin, L. T., Chen, J. W., Yang, C. M., Chang, J. H., et al. (2001). Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999. Int. J. Hematol. 74, 333-337.
202. Machuca, A., Tuset, C., Soriano, V., Caballero, E., Aguilera, A., and Ortiz de Lejarazu, R. (2000). Prevalence of HTLV infection in pregnant women in Spain. Sex. Transm. Infect. 76, 366-370.
203. Maeda, Y., Furukawa, M., Takehara, Y., Yoshimura, K., Miyamoto, K., Mat-suura, T., et al. (1984). Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int. J. Cancer 33, 717-720.
204. Maehama, T. (2004). Human T cell leukemia virus-1 in pregnancy. Int. J. Gynaecol. Obstet. 87,247-248.
205. Mahe, A., Gessain, A., Huerre, M., Valensi, F., Keita, S., and Bobin, P. (1994). Adult T-cell leukemia associated with HTLV-1 in a HIV-2 seropositive African. Ann. Dermatol. Venereol. 121, 704-709.
206. Mahieux, R., Chappey, C., Georges-Courbot, M. C., Dubreuil, G., Mau-clere, P., Georges, A., et al. (1998). Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D.J.Virol. 72, 10316-10322.
207. Mahieux, R., and Gessain, A. (2009). The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol. 57, 161-166.
208. Mahieux, R., Gessain, A., Truffert, A., Vitrac, D., Hubert, A., Dandelot, J., et al. (1994). Seroepidemiol-ogy, viral isolation, and molecular characterization of human T cell leukemia/lymphoma virus type I from La Reunion Island, Indian Ocean. AIDS Res. Hum. Retroviruses 10, 745-752.
209. Mahieux, R., Horal, P., Mauclere, P., Mercereau-Puijalon, O., Guillotte, M., Meertens, L., et al. (2000). Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection. J. Clin. Microbiol. 38, 4049-4057.
210. Mahieux, R., Ibrahim, F., Mauclere, P., Herve, V., Michel, P., Tekaia, F., et al. (1997). Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies. J. Virol. 71, 1317-1333.
211. Maloney, E. M., Yamano, Y., Vanveld-huisen, P. C., Sawada, T., Kim, N., Cranston, B., et al. (2006). Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. J. Infect. Dis. 194, 552-560.
212. Manca, N., Ferremi, P., De Simone, N., Pirali, F., and Turano,A. (1997). Isolation of HTLV-1 from an aggressive form of ATL in a Romanian patient not at risk of infection and with seronegative family members. New Microbiol. 20, 177-185.
213. Mansuy, J. M., Schlegel, L., Villeneuve, L., Mengelle, C., and Magnaval, J. E (1999). Seroprevalence of retro-viral infections among pregnant women in Martinique (French West Indies). Am. J. Trop. Med. Hyg. 61, 598-599.
214. Marin, O., Hasui, K., Remondegui, C., Sato, E., Aye, M. M., Take-nouchi, N., et al. (2002). Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina. Pathol. Int. 52, 348-357.
215. Martin, F., Fedina, A., Youshya, S., and Taylor, G. P. (2010). A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopa-thy in the UK. J. Neurol. Neurosurg. Psychiatr. 81, 1336-1340.
216. Mauclère, P., Afonso, P., Meertens, L., Plancoulaine, S., Calattini, S., Fro-ment, A., et al. (2011). HTLV-2B strains, similar to those found in several Amerindians tribes, are endemic in Centra African Bakola Pygmies. J. Infect. Dis. 203, 1316-1323.
217. Mauclere, P., Le Hesran, J. Y., Mahieux, R., Salla, R., Mfoupouendoun, J., Abada, E. T., et al. (1997). Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I gag-indeterminate Western blots in Central Africa. J. Infect. Dis. 176, 505-509.
218. May, J. T., Stent, G., and Schnagl, R. D. (1988). Antibody to human T-cell lymphotropic virus type I in Australian aborigines. Med. J. Aust. 149, 104.
219. Meertens, L., Rigoulet, J., Mauclere, P., Van Beveren, M., Chen, G. M., Diop, O., et al. (2001). Molecular and phy-logenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology 287,275-285.
220. Michel, P., Develoux, M., Talarmin, F., Ndiaye, P., Ndiaye, M., Raphenon, G., et al. (1996). Pathologies associated with HTLV-1 virus in Dakar (1992-1995). Med. Trop. (Mars) 56, 249-254.
221. Miller, M., Achiron, A., Shaklai, M., Stark, P., Maayan, S., Hannig, H., et al. (1998). Ethnic cluster of HTLV-I infection in Israel among the Mashhadi Jewish population. J. Med. Virol. 56,269-274.
222. Miura, T., Fukunaga, T., Igarashi, T., Yamashita, M., Ido, E., Funahashi, S., et al. (1994). Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc. Natl. Acad. Sci. U.S.A. 91, 1124-1127.
223. Mochizuki, M., Watanabe, T., Yam-aguchi, K., Tajima, K., Yoshimura, K., Nakashima, S., et al. (1992). Uveitis associated with human T lymphotropic virus type I: seroepi-demiologic, clinical, and virologic studies.J. Infect. Dis. 166, 943-944.
224. Mojaat, N., Kaabi, H., Hmida, S., Maa-mar, M., Slama, S., and Boukef, K. (1999). Seroprevalence of HTLV-I/II antibodies in blood donors and different groups at risk in Tunisia. J. Acquir. Immune Defic. Syndr. 22, 314-315.
225. Mowbray, J., Mawson, S., Chawira, A., Skidmore, S., Boxall, E., Desselberger, U., et al. (1989). Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopu-lation of Afro-Caribbean origin in England. J. Med. Virol. 29,289-295.
226. Muchinik, G., Bouzas, M. B., Zapiola, I., Decaro, J., Garcia, L., Gallo, D., et al. (1992). HTLV-I and HTLV-II infection in Uruguay. J. Acquir. Immune Defic. Syndr. 5, 743-744.
227. Mueller, N. (1991). The epidemiology of HTLV-I infection. Cancer Causes Control 2, 37-52.
228. Murphy, E. L., Figueroa, J. P., Gibbs, W. N., Brathwaite, A., Holding-Cobham, M., Waters, D., et al. (1989). Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med. 111, 555-560.
229. Murphy, E. L., Figueroa, J. P., Gibbs, W. N., Holding-Cobham, M., Cranston, B., Malley, K., et al. (1991). Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am. J. Epidemiol. 133,1114-1124.
230. Murphy, E. L., Watanabe, K., Nass, C. C., Ownby, H., Williams, A., and Nemo, G. (1999). Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J. Infect. Dis. 180,1777-1783.
231. Naman, R., Klayme, S., Naboulsi, M., Mokhbat, J., Jradi, O., and Ramia, S. (2002). HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon. J. Infect. 45, 29-31.
232. Nerrienet, E., Meertens, L., Kfutwah, A., Foupouapouognigni, Y., and Gessain, A. (2001). Molecular epidemiology of simian T-lymphotropic virus (STLV) in wild-caught monkeys and apes from Cameroon: a new STLV-1, related to human T-lymphotropic virus subtype F, in a Cercocebus agilis. J. Gen. Virol. 82, 2973-2977.
233. Nicholson, S. R., Efandis, T., Dimi-trakakis, M., Karopoulos, A., Lee, H., andGust,I.D. (1992).HTLV-Iinfec-tion in selected populations in Australia and the western Pacific region. Med. J. Aust. 156,878-880.
234. Nightingale, S., Orton, D., Ratcliffe, D., Skidmore, S., Tosswill, J., and Desselberger, U. (1993). Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England. Epidemiol. Infect. 110,379-387.
235. Oger, J. J., Werker, D. H., Foti, D. J., and Dekaban, G. A. (1993). HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast? Can. J. Neurol. Sci. 20, 302-306.
236. Ohkura, S., Yamashita, M., Cartier, L., Tanabe, D. G., Hayami, M., Sonoda, S., et al. (1999). Identification and phylogenetic characterization of a human T-cell leukaemia virus type I isolate from a native inhabitant (Rapa Nui) of Easter Island. J. Gen. Virol. 80(Pt 8), 1995-2001.
237. Oki, T., Yoshinaga, M., Otsuka, H., Miyata, K., Sonoda, S., and Nagata, Y. (1992). A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan. Asia Oceania J. Obstet Gynaecol. 18,371-377.
238. Okochi, K., Sato, H., and Hinuma, Y. (1984). A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: serocon-version in recipients. Vox Sang. 46, 245-253.
239. Olaleye, D. O., Bernstein, L., Sheng, Z., Ekweozor, C. C., Li, X. Y., Sullivan-Halley, J., et al. (1994). Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria. Am. J. Trop. Med. Hyg. 50,479-486.
240. Olaleye, D. O., Ekweozor, C. C., Sheng, Z., and Rasheed, S. (1995). Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. Int. J. Epidemiol. 24, 198-203.
241. Olbrich Neto, J., and Meira, D. A. (2004). Soroprevalence of HTLV-I/II, HIV, siphylis and toxoplasmo-sis among pregnant women seen at Botucatu - Sao Paulo - Brazil: risk factors for HTLV-I/II infection. Rev. Soc. Bras. Med. Trop. 37,28-32.
242. Orland, J. R., Engstrom, J., Fridey, J., Sacher, R. A., Smith, J. W., Nass, C., et al. (2003). Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology 61, 1588-1594.
243. Osame, M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., et al. (1990). Nationwide survey of HTLV-I-associated myelopa-thy in Japan: association with blood transfusion. Ann. Neurol. 28, 50-56.
244. Ouattara, S. A., Gody, M., and de-The, G. (1989). Prevalence of HTLV-I compared to HIV-1 and HIV-2 antibodies in different groups in the Ivory Coast (West Africa). J. Acquir. Immune Defic. Syndr. 2, 481-485.
245. Padua, E., Rodes, B., Perez-Pinar, T., Silva, A. F., Jimenez, V., Ferreira, F., et al. (2011). Molecular characterization of human T cell leukemia virus type 1 subtypes in a group of infected individuals diagnosed in Portugal and Spain. AIDS Res. Hum. Retroviruses 27, 317-322.
246. Park, J. H., Lee, B. I., Chun, S. I., and Osame, M. (1991). A case of HTLV-I associated myelopa-thy(HAM) in Korea. Yonsei Med. J. 32, 190-194.
247. Paun, L., Ispas, O., Del Mistro, A., and Chieco-Bianchi, L. (1994). HTLV-I in Romania. Eur. J. Haematol. 52, 117-118.
248. Payne, L. J., Tosswill, J. H., Taylor, G. P., Zuckerman, M., and Simms, I. (2004). In the shadow of HIV-HTLV infection in England and Wales, 1987-2001. Commun. Dis. Public Health 7, 200-206.
249. Pepin, J., Labbe, A. C., Mamadou-Yaya, F., Mbelesso, P., Mbadingai, S., Deslandes, S., et al. (2010). Iatro-genic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa. Clin. Infect. Dis. 51, 777-784.
250. Peters, A. A., Coulthart, M. B., Oger, J. J., Waters, D. J., Crandall, K. A., Baumgartner, A. A., et al. (2000). HTLV type I/II in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type IIa isolate. AIDS Res. Hum. Retroviruses 16, 883-892.
251. Picard, F. J., Coulthart, M. B., Oger, J., King, E. E., Kim, S., Arp, J., et al. (1995). Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins. J. Virol. 69, 7248-7256.
252. Plancoulaine, S., Buigues, R. P., Murphy, E. L., van Beveren, M., Pouliquen, J. E, Joubert, M., et al. (1998). Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int. I Cancer 76, 331-336.
253. Plumelle, Y., Pascaline, N., Nguyen, D., Panelatti, G., Jouannelle, A., Jouault, H., et al. (1993). Adult T-cell leukemia-lymphoma: a clinico-pathologic study of twenty-six patients from Martinique. Hematol. Pathol. 7,251-262.
254. Poiesz, B. J., Papsidero, L. D., Ehrlich, G., Sherman, M., Dube, S., Poiesz, M., et al. (2001). Prevalence of HTLV-I-associated T-cell lymphoma. Am. J. Hematol. 66, 32-38.
255. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77,7415-7419.
256. Polizzotto,M. N.,Wood, E. M.,Ingham, H., and Keller, A. J. (2008). Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 48, 55-63.
257. Poljak, M., Bednarik, J., Rednak, K., Seme, K., Kristancic, L., and Celan-Lucu, B. (1998). Seroprevalence of human T cell leukaemia/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereo-logical outpatient services and intravenous drug users from Slovenia. Folia Biol. (Praha) 44, 23-25.
258. Pombo De Oliveira, M. S. (1996). HTLV-1 infection and adultT-cell leukemia in Brazil: an overview. Sao. Paulo Med. J. 114,1177-1185.
259. Porter, K. R., Anthony, R. L., Solihin, A., and Hayes, C. G. (1995). Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falci-parum antibodies. J. Med. Virol. 45, 469-474.
260. Pouliquen, J. F., Hardy, L., Lavergne, A., Kafiludine, E., and Kazanji, M. (2004). High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana). J. Clin. Micro-biol. 42,2020-2026.
261. Power, C., Weinshenker, B. G., Dekaban, G. A., Ebers, G. C., Francis, G. S., and Rice, G. P. (1989). HTLV-1 associated myelopathy in Canada. Can. J. Neurol. Sci. 16, 330-335.
262. Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C., and Murphy, E. L. (2005). Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058-6068.
263. Qiu, X., Hodges, S., Lukaszewska, T., Hino, S., Arai, H., Yamaguchi, J., et al. (2008). Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies. J. Med. Virol. 80, 484-493.
264. Quispe, N. C., Feria, E. B., Santos-Fortuna Ede, L., and Caterino-de-Araujo, A. (2009). Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru. Rev. Inst. Med. Trop. Sao Paulo 51,25-29.
265. Rafatpanah, H., Hedayati-Moghaddam, M. R., Fathimoghadam, F., Bidkhori, H. R., Shamsian, S. K., Ahmadi, S., et al. (2011). High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J. Clin. Virol. 52,172-176.
266. Rajabalendaran, N., Burns, R., Molli-son, L. C., Blessing, W., Kirubakaran, M. G., and Lindschau, P. (1993). Tropical spastic paraparesis in an aborigine. Med. J. Aust. 159, 28-29.
267. Ramalingam, S., Kannangai, R., Prakash, K. J., Ajithkumar, K., Jacob, M., George, R., et al. (2001). A pilot study of HTLV-I infection in high-risk individuals & their family members from India. Indian J. Med. Res. 113,201-209.
268. Re, M. C., Tommaseo, M., Furlini, G., andLaPlaca,M. (1989).High prevalence of serum antibody against human T cell leukemia virus type I (HTLV-I) among the Bismam Asmat population (Indonesian New Guinea). AIDS Res. Hum. Retroviruses 5,551-554.
269. Reddy, D., Okochi, K., Woodfield, D. G., and Judd, W (1987). Absence of HTLV I from New Zealand. J. Med. Virol. 22, 375-378.
270. Reeves, W. C., Levine, P. H., Cuevas, M., Quiroz, E., Maloney, E., and Saxinger,W.C.(1990). Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama. Am. J. Trop. Med. Hyg. 42, 374-379.
271. Riedel, D. A., Evans, A. S., Saxinger, C., and Blattner, W A. (1989). A historical study of human T lymphotropic virus type I transmission in Barbados. J. Infect. Dis. 159, 603-609.
272. Rio, B., Louvet, C., Gessain, A., Dor-mont, D., Gisselbrecht, C., Mar-toia, R., et al. (1990). Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa. PresseMed. 19,746-751.
273. Rodgers-Johnson, P., Morgan, O. S., Mora, C., Sarin, P., Ceroni, M., Pic-cardo, P., et al. (1988). The role of HTLV-I in tropical spastic paraparesis in Jamaica. Ann. Neurol. 23(Suppl.),S121-S126.
274. Roman, G. C., Schoenberg, B. S., Madden, D. L., Sever, J. L., Hugon, J., Ludolph, A., et al. (1987). Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles. Arch. Neurol. 44, 605-607.
275. Roucoux, D. F., Wang, B., Smith, D., Nass, C. C., Smith, J., Hutching, S. T., et al. (2005). A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J. Infect. Dis. 191, 1490-1497.
276. Rouet, F., Foucher, C., Rabier, M., Gawronski, I., Taverne, D., Chancerel, B., et al. (1999a). Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics. Transfusion 39, 639-644.
277. Rouet, F., Rabier, R., Foucher, C., Chancerel, B., Agis, F., and Strobel, M. (1999b). Geographical clustering of human T-cell lymphotropic virus type I in Guadeloupe, an endemic Caribbean area. Int. J. Cancer 81, 330-334.
278. Safai, B., Huang, J. L., Boeri, E., Farid, R., Raafat, J., Schutzer, P., et al. (1996). Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res. Hum. Retroviruses 12,1185-1190.
279. Saito, M., Moritoyo, T., Park, J. H., Lee, B. I., Kim, J. S., Fujisawa, J., et al. (1993). Nucleotide sequence analysis of HTLV-I isolate from a Korean patient with HAM/TSP. Yonsei Med. J.34,321-327.
280. Salemi, M., Van Dooren, S., Aude-naert, E., Delaporte, E., Goubau, P., Desmyter, J., et al. (1998). Two new human T-lymphotropic virus type I phylogenetic subtypes in seroin-determinates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. Virology 246, 277-287.
281. Sanchez-Palacios, C., Gotuzzo, E., Van-damme, A. M., and Maldonado, Y. (2003). Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women. Int. J. Infect. Dis. 7,132-137.
282. Sanders, R. C., Wai'in, P. M., Alexander, S. S., Levin, A. G., Blattner, W. A., and Alpers, M. P. (1993). The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea. Arch. Virol. 130, 327-334.
283. Sarkodie, F., Adarkwa, M., Adu-Sarkodie, Y., Candotti, D., Acheam-pong, J. W., and Allain, J. P. (2001). Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang. 80, 142-147.
284. Satake, M., Yamaguchi, K., and Tadokoro, K. (2012). Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J. Med. Virol. 84, 327-335.
285. Saxinger, W., Blattner, W. A., Levine, P. H., Clark, J., Biggar, R., Hoh, M., et al. (1984). Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 225, 1473-1476.
286. Schill, P. H., Bruneau, B., Le Page, B., Humeau, O., Grimault, C., Tam-preau, V., et al. (1989). Seroprevalence of anti-HIV antibodies in a rural Haitian population. Bull. Soc. Pathol. Exot. Filiales 82, 308-315.
287. Schreiber, G. B., Murphy, E. L., Hor-ton, J. A., Wright, D. J., Garfein, R., Chien, H. C., et al. (1997). Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the retrovirus epidemiology donor study. NHLBI retrovirus epidemiology donor study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 263-271.
288. Schrijvers, D., Delaporte, E., Peeters, M., Dupont, A., and Meheus, A. (1991). Seroprevalence of retroviral infection in women with different fertility statuses in Gabon, western equatorial Africa. J. Acquir. Immune Defic. Syndr. 4, 468-470.
289. Segurado, A., Granade, T., Parekh, B., Nunez, C. A., Meza, R., Amador, L., et al. (1997). Presence of HTLV-I and HTLV-II infection in Honduras. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16, 308.
290. Sene-Diouf, F., Ndiaye, M., Diop, A. G., Thiam, A., Ndao, A. K., Diagne, M., et al. (2000). Epidemiological, clinical and progressive aspects of neurological manifestations associated with retroviral infections: eleven year retrospective study. Dakar Med. 45, 162-166.
291. Seniuta, N. B., Iakovleva, L. S., Stepina, V N., Buachidze, L. N., Gurova, E. P., Kologrivova, Z. A., et al. (1990). Screening of sera from the adult populations of some USSR regions for antibodies to the human T-cell leukemia virus type I (HTLV-I). Vopr. Virusol. 35, 309-312.
292. Senyuta, N., Syrtsev, A., Yamashita, M., Stepina, V., Susova, O., Scherbak, L., et al. (1998). Sero-epidemiologic and phylogenetic studies of HTLV-I infection in 2 countries of the Caspian Sea region. Int. J. Cancer 77, 488-493.
293. Sertoz, R., Turhan, A., Bozkurt, H., Samlioglu, P., Degirmenci, A., Aydi-nok, Y., et al. (2010). Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey. Mikrobiyol. Bul. 44, 579-584.
294. Seyfert, S., Faulstich, A., and Marx, P. (2004). What determines the CSF concentrations of albumin and plasma-derived IgG? J. Neurol. Sci. 219,31-33.
295. Shtalrid, M., Shvidel, L., Korenfeld, R., Duek, A., Landau, Z., and Berrebi, A. (2005). HTLV-1 associated adult T-cell leukemia/lymphoma in Israel: report of two patients of Romanian origin. Haematologica 90, ECR13.
296. Sidi, Y., Meytes, D., Shohat, B., Fenig, E., Weisbort, Y., Lee, H., et al. (1990). Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer 65, 590-593.
297. Silva Cabrera, E., Perez Guevara, M. T., Lubian Caballero, A. L., de la Fuente Arzola, J. L., Navea Leyva, L., and Cruz Sui, O. (1997). Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups. Rev. Cubana. Med. Trop. 49, 24-27.
298. Singhal, B. S., Lalkaka, J. A., Sonoda, S., Hashimoto, K., Nomoto, M., Kub-ota, R., et al. (1993). Human T-lymphotropic virus type I infections in western India. AIDS 7,138-139.
299. Stienlauf, S., Yahalom, V., Schwartz, E., Shinar, E., Segal, G., and Sidi, Y. (2009). Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel. Emerging Infect. Dis. 15, 1116-1118.
300. Stuver, S. O., Tachibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., et al. (1993). Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J. Infect. Dis. 167,57-65.
301. Tajima, K. (1990). The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int. J. Cancer 45, 237-243.
302. Tajima, K., Kamura, S., Ito, S., Ito, M., Nagatomo, M., Kinoshita, K., et al. (1987). Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based cooperative study in Tsushima, Japan. Int.J. Cancer 40,741-746.
303. Takahashi, K., Takezaki, T., Oki, T., Kawakami, K., Yashiki, S., Fujiyoshi, T., et al. (1991). Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group. Int. J. Cancer 49, 673-677.
304. Takao, S., Ishida, T., Bhatia, K. K., Saha, N., Soemantri, A., and Kayame, O. W. (2000). Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria. J. Clin. Virol. 16, 129-133.
305. Takezaki, T., Tajima, K., Komoda, H., and Imai, J. (1995). Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J. Infect. Dis. 171,559-565.
306. Tanggo, Y., Gultom, S. P., Simanjun-tak, T., Sibuea, W H., Matsuzaki, H., and Yamaguchi, K. (2000). Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various non-hematological diseases. Intervirology 43, 77-79.
307. Taylor, G. P., Bodeus, M., Courtois, F., Pauli, G., Del Mistro, A., Machuca, A., et al. (2005). The seroepide-miology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J. Acquir. Immune Defic. Syndr. 38, 104-109.
308. Taylor, M. B., Parker, S. P., Crewe-Brown, H. H., McIntyre, J., and Cubitt, W. D. (1996). Seroepidemi-ology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers. Epidemiol. Infect. 117, 343-348.
309. Temple, J. J., Brammer, M. G., Andes, W. A., Covington, S., and Rangan, S. (1986). Adult T-cell leukemia-lymphoma. Unusual features of two patients from a low-incidence area. Cancer 58, 694-698.
310. Thyss, A., Michiels, J. F., Ayela, P., Lagrange, M., Hoffman, P., and Schneider, M. (1990). Leukemia/lymphoma T syndrome associated with HTLV 1 in a patient of Moroccan origin. Presse Med. 19, 135.
311. Toro, C., Rodes, B., Aguilera, A., Caballero, E., Benito, R., Tuset, C., et al. (2002). Clinical impact of HTLV-1 infection in Spain: implications for public health and mandatory screening. J. Acquir. Immune Defic. Syndr. 30, 366-368.
312. Tortevoye, P., Tuppin, P., Carles, G., Peneau, C., and Gessain, A. (2005). Comparative trends of seroprevalence and seroincidence rates of human T cell lymphotropic virus type I and human immunodeficiency virus 1 in pregnant women of various ethnic groups sharing the same environment in French Guiana. Am. J. Trop. Med. Hyg. 73, 560-565.
313. Tortevoye, P., Tuppin, P., Peneau, C., Carles, G., and Gessain, A. (2000). Decrease of human T-cell lymphotropic virus type I prevalence and low incidence among pregnant women from a high endemic ethnic group in French Guiana. Int. J. Cancer 87, 534-538.
314. Trejo-Avila, L. M., Fuentes-Pensamiento, R., Scorro Flores-Castaneda, M., Diaz-Mendoza, M. L., Zapata-Benavides, P., and Tamez-Guerra, R. S. (1996). Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico. Arch. Med. Res. 27,97-99.
315. Trenchi, A., Gastaldello, R., Balangero, M., Irizar, M., Cudola, A., and Gal-lego, S. (2007). Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina. J. Med. Virol. 79, 1974-1978.
316. Trevino, A., Aguilera, A., Caballero, E., Benito, R., Parra, P., Eiros, J. M., et al. (2012). Trends in the prevalence and distribution of HTLV-1 andHTLV-2 infections in Spain. Virol. J. 9, 71.
317. Trujillo, J. M., Concha, M., Munoz, A., Bergonzoli, G., Mora, C., Bor-rero, I., et al. (1992). Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia. AIDS Res. Hum. Retroviruses 8, 651-657.
318. Tseliou, P. M., Spanakis, N., Spiliotakara, A., Markogiannakis, A., Legakis, N. J., and Tsakris, A. (2006). Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. Int. J. STD AIDS 17,543-546.
319. Tseliou, P. M., Spiliotakara, A., Politis, C., Spanakis, N., Legakis, N. J., and Tsakris, A. (2004). Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reac-tivities in a Greek blood bank population. Transfus Med 14, 253-254.
320. Tuppin, P., Makuwa, M., Guerma, T., Bazabana, M. M., Loukaka, J. C., Jeannel, D., et al. (1996). Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate western blot pattern. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11, 105-107.
321. Tuset, C., Gutierrez, M., Carbonell, C., Tuset, T., and Soriano, V (1997). Human T-cell lymphotropic virus infection in pregnant women in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 16, 771-773.
322. Ueda, K., Kusuhara, K., Tokugawa, K., Miyazaki, C., Yoshida, C., Tokumura, K., et al. (1989). Cohort effect on HTLV-I seroprevalence in southern Japan. Lancet 2, 979.
323. Umemoto, M., Take, H., Kusuhara, K., andKuraya,K. (1994).Marriage patterns among HTLV-I seropositive women in Japan. Cancer Lett. 81, 237-240.
324. Ureta-Vidal, A., Angelin-Duclos, C., Tortevoye, P., Murphy, E., Lepere, J. F., Buigues, R. P., et al. (1999). Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int. J. Cancer 82, 832-836.
325. Vallejo, A., Dubon, J. M., and Garcia-Saiz, A. (1996). Presence of human T-cell lymphotropic virus types I and II infections in Honduras. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12, 529-530.
326. van der Ryst, E., Joubert, G., Smith, M. S., Terblanche, M., Mollentze, F., andPretorius,A.M. (1996). HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study. Cent. Afr. J. Med. 42, 65-68.
327. van Doornum, G. J., Hooykaas, C., Huisman, J. G., van der Linden, M. M., and Coutinho, R. A. (1990). Prevalence of human T-cell leukemia virus antibody among heterosexuals living in Amsterdam, The Netherlands. J. Med. Virol. 32, 183-188.
328. Vandamme, A. M., Salemi, M., and Desmyter, J. (1998). The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol. 6, 477-483.
329. Vasquez, P., Sanchez, G., Volante, C., Vera, L., Ramirez, E., Soto, G., et al. (1991). Human T-lymphotropic virus type I: new risk for Chilean population. Blood 78, 850-851.
330. Veelken, H., Kohler, G., Schneider, J., Dierbach, H., Mertelsmann, R., Schaefer, H. E., et al. (1996). HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest, Romania. Leukemia 10, 1366-1369.
331. Verdier, M., Bonis, J., and Denis, F. (1994). "The Prevalence and Incidence of HTLVs in Africa," in AIDS in Africa, eds M. Essex, S. Mboup, P. Kanki, and M. Kalengayi (NewYork: Raven Press, Ltd.), 173-192.
332. Verdier, M., Denis, F., Sangare, A., Barin, E, Gershy-Damet, G., Rey, J. L., et al. (1989). Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa.J. Infect. Dis. 160, 363-370.
333. Verdonck, K., Gonzalez, E., Van Dooren, S., Vandamme, A. M., Vanham,G.,andGotuzzo,E. (2007). Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet. Infect. Dis. 7, 266-281.
334. Vernant, J. C., Maurs, L., Gessain, A., Barin, F., Gout, O., Delaporte, J. M., et al. (1987). Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann. Neurol. 21, 123-130.
335. Voevodin, A., al-Mufti, S., Farah, S., Khan, R., and Miura, T. (1995). Molecular characterization of human T-lymphotropic virus, type 1 (HTLV-1) found in Kuwait: close similarity with HTLV-1 isolates originating from Mashhad, Iran. AIDS Res. Hum. Retroviruses 11, 1255-1259.
336. Vrielink, H., and Reesink, H. W. (2004). HTLV-I/II prevalence in different geographic locations. Transfus. Med. Rev. 18,46-57.
337. Wang, H. R., Yan, Y. S., Zhang, Q. W., Zheng, J., Liu, J. M., Feng, Y. Y., et al. (2004). Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province. Zhonghua Liu Xing Bing Xue Za Zhi 25, 428-430.
338. Wang, Y., Li, X., Song, A., Zhang, C., Chen, Y., Chen, C., et al. (2005). Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China. J. Med. Virol. 76, 613-618.
339. Watanabe, T. (2011). Current status of HTLV-1 infection. Int. J. Hematol. 94, 430-434.
340. Watanabe, T., Seiki, M., Tsujimoto, H., Miyoshi, I., Hayami, M., and Yoshida, M. (1985). Sequence homology of the simian retro-virus genome with human T-cell leukemia virus type I. Virology 144, 59-65.
341. Whyte, G. S. (1997). Is screening of Australian blood donors for HTLV-I necessary? Med. J. Aust. 166, 478-481.
342. Wiktor, S. Z., Pate, E. J., Murphy, E. L., Palker, T. J., Champegnie, E., Ram-lal,A.,etal. (1993). Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epi-topes.J. Acquir. Immune Defic. Syndr. 6, 1162-1167.
343. Wiktor, S. Z., Piot, P., Mann, J. M., Nzil-ambi, N., Francis, H., Vercauteren, G., et al. (1990). Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. J. Infect. Dis. 161, 1073-1077.
344. Williams, A. E., Fang, C. T., Sla-mon, D. J., Poiesz, B. J., Sandler, S. G., Darr, W. F. II, et al. (1988). Seroprevalence and epidemiologi-cal correlates of HTLV-I infection in U.S. blood donors. Science 240, 643-646.
345. Williams, C. K., Alexander, S. S., Bodner, A., Levine, A., Saxinger, C., Gallo, R. C., et al. (1993). Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria. Br. J. Cancer 67, 783-786.
346. Williams, C. K., Dada, A., and Blat-tner, W. A. (1994). Some epidemio-logical features of the human T-cell lymphotropic virus type I (HTLV-I) and ATL in Nigerians. Leukemia 8 (Suppl. 1),S77-S82.
347. Wolfe, N. D., Heneine, W., Carr, J. K., Garcia, A. D., Shanmugam, V., Tamoufe, U., et al. (2005). Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc. Natl. Acad. Sci. U.S.A. 102, 7994-7999.
348. Yamaguchi, K., Inaoka, T., Ohtsuka, R., Akimichi, T., Hongo, T., Kawabe, T., et al. (1993). HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey. Jpn. J. Cancer Res. 84,715-719.
349. Yanagihara, E. T., Blaisdell, R. K., Hayashi, T., and Lukes, R. J. (1989). Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey. Hematol. Oncol. 7, 219-232.
350. Yanagihara, R. (1994). Geographic-specific genotypes or topotypes of human T-cell lymphotropic virus type I as markers for early and recent migrations of human populations. Adv. Virus Res. 43, 147-186.
351. Yanagihara, R., Ajdukiewicz, A. B., Garruto, R. M., Sharlow, E. R., Wu, X. Y., Alemaena, O., et al. (1991). Human T-lymphotropic virus type I infection in the Solomon Islands. Am. J. Trop. Med. Hyg. 44, 122-130.
352. Yanagihara, R., Jenkins, C. L., Alexander, S. S., Mora, C. A., and Garruto, R. M. (1990). Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. J. Infect. Dis. 162, 649-654.
353. Ydy, R. R., Ferreira, D., Souto, E J., and Fontes, C. J. (2009). Prevalence of human T-cell lymphotropic virus (HTLV-1/2) infection among puerperae in Cuiaba, Mato Grosso, 2006. Rev. Soc. Bras. Med. Trop. 42, 28-32.
354. Yim, M., Hayashi, T., Yanagihara, E., Kadin, M., and Nakamura, J. (1986). HTLV-I-associated T-cell leukemia in Hawaii. Am. J. Med. Sci. 292, 325-327.
355. Zaaijer, H. L., Cuypers, H. T., Dudok de Wit, C., and Lelie, P. N. (1994). Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion 34, 877-880.
356. Zabaleta, M., Peralta, J., Birges, J., Bianco, N., and Echeverria de Perez, G. (1994). HTLV-I-associated myelopathy in Venezuela. J. Acquir. Immune Defic. Syndr. 7, 1289-1290.
357. Zaninovic, V., Arango, C., Biojo, R., Mora, C., Rodgers-Johnson, P., Concha, M., et al. (1988). Tropical spastic paraparesis in Colombia. Ann. Neurol. 23(Suppl.), S127-S132.
358. Zaninovic, V., Sanzon, F., Lopez, E, Velandia, G., Blank, A., Blank, M., et al. (1994). Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia. AIDS Res. Hum. Retroviruses 10, 97-101.
359. Zhuo, J., Yang, T., Zeng, Y., and Lu, L. (1995). Epidemiology of anti-human T-cell leukemia virus type I antibody and characteristics of adult T-cell leukemia in China. Chin. Med. J. 108, 902-906.
360. Zoulek, G., Schatzl, H., Kawabata, M., de Cabral, M. B., Cabello, A., Freutsmiedl, K., et al. (1992). A seroepidemiological survey of antibodies to HTLV-I/HTLV-II in selected population groups in Paraguay. Scand. J. Infect. Dis. 24, 397-398.
361. Zurita, S., Costa, C., Watts, D., Inda-cochea, S., Campos, P., Sanchez, J., et al. (1997). Prevalence of human retroviral infection in Quillabamba and Cuzco, Peru: a new endemic area for human T cell lymphotropic virus type 1. Am. J. Trop. Med. Hyg. 56, 561-565.